Payment Method - A/B MACs (A) and (B)

50.3 - Payment Method - A/B MACs (A) and (B) (Rev. 11902; Issued:03-16-23; Effective: 04-17-23; Implementation: 04-17-23) Screening PSA tests (G0103) are paid under the clinical diagnostic lab fee schedule. Screening PSA tests (Effective 01/01/23 (0359U)) new codes are contractor-priced (where applicable) until they are nationally priced and undergo the CLFS annual payment determination process. Screening rectal examinations (G0102) are paid under the MPFS except for the following bill types identified (A/B MAC (A) only). Bill types not identified are paid under the MPFS. 12X = Outpatient Prospective Payment System 13X = Outpatient Prospective Payment System 14X-=Outpatient Prospective Payment System 71X = Included in All Inclusive Rate 73X = Included in All Inclusive Rate 85X = Cost (Payment should be consistent with amounts paid for code 84153 or code 86316.) Effective 4/1/06 the type of bill 14X is for non-patient laboratory specimens. The RHCs and FQHCs should include the charges on the claims for future inclusion in encounter rate calculations.